Heart Disease & Stroke Prevention Program and Diabetes Prevention - State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke

 

The purpose of this program is to support implementation of population-wide and priority population approaches to prevent obesity, diabetes, and heart disease and stroke and reduce health disparities in these areas among adults.

Deleted 03/27/2024 (Archived.) 93.813 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. This program is authorized under section 301(a) and 317(k) of the Public Health Service Act, 42 U.S.C. section 241 and 247b(k)(2), and Title IV Section 4002 of the Affordable Care Act, Prevention and Public Health Fund. And, additional authorities apply to certain diabetes-related activities concerning behavioral interventions, Sections 399V-3 and 1703(a) of the Public health Service Act, 42 U.S.C 280g-14 and 300u-2 Eligible Applicants: State Departments of Health or their Bona Fide Agents (includes the District of Columbia) 2. Large city health departments or their bona fide agents, with populations of at least 900,000 (using July 2012 U.S. census Estimates xviii) 3.Special Eligibility Requirements: Large city applicants must work in partnership with and provide a letter of support from the state department of health or its bona fide agent documenting activities proposed. States and communities will benefit from this assistance in many ways including through improved clinical and other preventive services for self-management of hypertension, diabetes, overweight and obesity Applicants should document the need for assistance, State the objectives of the project, outline the method of operation, describe evaluation procedures, and provide a budget with justification for funds requested. Costs will be determined in accordance with 2 CFR Part 225, 45 CFR Part 92, OMB Circular No. A-102, and OMB Circular A-133. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. n/a 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Submit Annual Progress Reports through www.Grants.gov. If you encounter any difficulties submitting your interim progress report through www.Grants.gov, please contact CDC's Technical Information Management Section at (770) 488-2700 prior to the submission deadline. If further information is needed regarding the application process, please contact the CDC Procurement and Grants Office at (770) 488-2710 located at 2920 Brandywine Road, Atlanta, GA 30341 After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public, initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. However, applicants are encouraged to call CDC for programmatic technical assistance prior to the development and submission of their assistance application. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. Not applicable. From 120 to 180 days. Renewals will be based upon the availability of funding and satisfactory programmatic progress. Project period is for 4 years with 12 month budget periods Continuation applications will undergo a technical review prior to award. A summary statement will be provided which may or may not require a grantee response. For any supplemental funding all applications will be reviewed initially for completeness by CDC PGO staff and will be reviewed jointly for eligibility by the CDC NCCDPHP and PGO. Incomplete applications and applications that do not meet the eligibility criteria will not advance to Phase II review. Applicants will be notified that their applications did not meet eligibility or published submission requirements. A review panel will evaluate complete, eligible applications in accordance with the "Criteria" section of the FOA. There may or may not be an additional review which will be provided in the FOA. Not more than thirty days after the Phase II review is completed, applicants will be notified electronically if their application does not meet eligibility or published submission requirements. Continue to build on public health activities such as partnership engagement, workforce development, guidance and support for programmatic efforts, strategic communication, surveillance and epidemiology, and evaluation. Continue to extend the activities supported with basic funding under DP13-1305 under enhanced component to achieve even greater reach and impact through implementation of evidence-based strategies that are more extensive and wider-reaching than those implemented in the basic component. Supplemental funding may be provided that is specific to a chronic disease such as diabetes and/or heart disease and/or risk factor(s). Funds may be used for costs associated with planning, implementing, and evaluating chronic disease prevention and control programs Performance Reports: Awardees should have already provided (unless supplemental funding is awarded in other years that would require this as new)a more detailed evaluation and performance measurement plan within the first six months of this project. This more detailed plan must be developed by awardees as part of first-year project activities, with support from CDC, must build on the elements stated in the initial plan, and must be no more than 25 pages. Awardees are required to submit performance measures annually as a minimum, and may require reporting more frequently. Performance measure reporting is limited to data collection. When funding was awarded initially, CDC program specified required reporting frequency, data fields, and format. Not applicable. Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the end of a budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. 12-month budget period within a 5-year project period Method of awarding/releasing assistance: Lump. None/Not specified. Robert Hancock
4770 Buford Highway, MS F75
Atlanta, GA 30341 US
rnh2@cdc.gov
Phone: 7704881431 http://www.cdc.gov 75-0948-0-1-550 (Cooperative Agreements) FY 18$69,500,000.00; FY 19 est $0.00; FY 20 est $0.00; FY 17$69,500,000.00; FY 16$69,500,000.00; - This number supports DP13-1305. This program ended in 2018 Actual amounts: FY2014: $69,530,534; Anticipated amounts - FY2015: $69,500,000, FY 2016 $69,500,000. The awards may range from $1,300,000 to $1,760,000 for component 1 and $1,300.000 to $1,760,000 for component 2, and $2,600,000 to $3,520,000 per applicant 92 CFR Part 225 and 45 CFR Part 92 Cost Principles for Grants and Cooperative Agreements with State and Local Governments (OMB Circular A-102) and Audits of State, Local Governments and Non-Profit Organizations (OMB Circular No. A-133) and Congress directed HHS guidance/requirements regarding terms and conditions and reporting requirements for recipients of programs supported with resources from the Prevention and Public Health Fund Not applicable.